| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Perrigo Co Plc (PRGO) has 20 insiders with recent SEC Form 4 filings, including 8 buys and 5 sells. PRGO is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 85.8K | $1.01M | - | |
| CFO | 57.6K | $679.3K | - | |
| Dir | 32.4K | $381.8K | - | |
| VP | 31.3K | $369.3K | - | |
| Dir | 30.6K | $361.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2024 | Doyle Katherine C. | Director | Sell | 8,954 | $27.30 | $244,444.20 | -59.8% | -0.6% | -19.7% | |
| Aug 26, 2024 | Janish Ronald Craig61 | EVP, Gbl Ops &Sc &CTO | Sell | 13,000 | $29.40 | $382,245.50 | -38.7% | -2.8% | -18.8% | |
| Aug 20, 2024 | Andersen Svend47 | EVP &President Chci | Sell | 34,983 | $27.69 | $968,560.28 | -17.8% | -3.3% | -14.9% | |
| May 28, 2024 | Andersen Svend47 | EVP &President Chci | Buy | 1,000 | $27.90 | $27,900.00 | +1.0% | +6.9% | -0.8% | |
| Mar 5, 2024 | Ives Alison57 | EVP &Chief Scientific Officer | Buy | 2,490 | $27.26 | $67,877.40 | +18.3% | +1.4% | +8.1% | |
| Mar 1, 2024 | Willis Robert55 | EVP &CHRO | Buy | 6,371 | $25.90 | $164,977.30 | +14.4% | +4.7% | +10.1% | |
| Feb 29, 2024 | Lockwood-Taylor Patrick48 | CEO | Buy | 9,500 | $26.54 | $252,168.00 | +86.4% | +3.6% | +10.4% | |
| Feb 29, 2024 | Ives Alison57 | EVP &Chief Scientific Officer | Buy | 1,545 | $26.44 | $40,849.80 | +14.2% | +3.6% | +10.4% | |
| Nov 24, 2023 | Willis Robert55 | EVP &CHRO | Buy | 5,550 | $31.01 | $172,105.50 | +40.9% | +3.0% | -9.1% | |
| Nov 16, 2023 | Ives Alison57 | EVP &Chief Scientific Officer | Buy | 2,040 | $29.34 | $59,853.60 | +24.5% | +8.0% | -8.2% |